Effect of PCSK9 Inhibitor on Contrast-Induced Acute Kidney Injury in Patients with Acute Myocardial Infarction Undergoing Intervention Therapy

Effect of PCSK9 Inhibitor on Contrast-Induced Acute Kidney Injury in Patients with Acute Myocardial Infarction Undergoing Intervention Therapy

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors have been shown to inhibit pyroptosis and apoptosis, which play important roles in the development and progression of contrast-induced acute kidney injury (CI-AKI). However, to the best of our knowledge, no studies have investigated th...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yu Ma, Lei Zha, Qi Zhang, Lu Cao, Ru Zhao, Jing Ma, Kai Hou, Yue Pan, Hongliang Cong, Ximing Li
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Series:	Cardiology Research and Practice
Online Access:	http://dx.doi.org/10.1155/2022/1638209
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prospects of Using PCSK9 Inhibitors for Acute Coronary Syndrome
by: A. M. Namitokov, et al.
Published: (2024-04-01)

PCSK9-antibodies fail to block PCSK9-induced inflammation in macrophages and cannot recapitulate protective effects of PCSK9-deficiency in experimental myocardial infarction
by: Simon Rauterberg, et al.
Published: (2025-01-01)

PCSK9 inhibitors reduces arterial stiffness in patients with acute coronary syndrome
by: Wang Liang, et al.
Published: (2025-01-01)

PCSK9 Modulates Macrophage Polarization-Mediated Ventricular Remodeling after Myocardial Infarction
by: Feifei Wang, et al.
Published: (2022-01-01)

PCSK9 Inhibitors: The Evolving Future
by: Bijay Mukesh Jeswani, et al.
Published: (2024-11-01)

ACE inhibitors in patients with acute myocardial infarction
by: S. N. Tereshchenko, et al.
Published: (2005-08-01)

PCSK9 inhibitors for in-hospital treatment of patients with acute coronary syndrome and severe lipid metabolism disorders
by: O. L. Barbarash, et al.
Published: (2020-09-01)

The benefits of PCSK9 inhibitors in patients with acute coronary syndrome: a systematic review and meta-analysis
by: Guanzhao Zhang, et al.
Published: (2024-03-01)

Short-term effects of PCSK-9 inhibitors on percutaneous coronary intervention in patients with acute coronary syndrome
by: Dong Hyun Gim, et al.
Published: (2025-05-01)

Analysis of The Use of PCSK9 Inhibitors in Clinical Practice
by: S. Yu. Volkova, et al.
Published: (2023-03-01)

Efficacy and safety of PCSK9 inhibitors in patients with chronic kidney disease
by: Haixia Tang, et al.
Published: (2025-08-01)

THE VALUES OF MATRIX METALLOPROTEASE-9 AND TISSUE METALLOPROTEASE INHIBITOR-1 IN ACUTE MYOCARDIAL INFARCTION WITH ANEURYSM FORMATION
by: A. V. Govorin, et al.
Published: (2014-07-01)

Efficacy and safety of PCSK-9 inhibitors in patients with acute coronary syndrome: a systematic review and network meta-analysis
by: Guoying Kao, et al.
Published: (2025-08-01)

The Role of PCSK9 Inhibitors in the Improvement of Outcomes in Patients after Acute Coronary Syndrome: Results of ODYSSEY OUTCOMES Trial
by: Yu. A. Karpov
Published: (2019-01-01)

PCSK9 in acute coronary syndrome: analysis of associations with clinical and laboratory characteristics
by: Yu. A. Drenina, et al.
Published: (2020-09-01)

Early effects of PCSK9 inhibitors: evolocumab versus alirocumab
by: Su-Hyun Bae, et al.
Published: (2025-03-01)

Pleiotropic Effects of PCSK9 Inhibitors on Cardio-Cerebrovascular Diseases
by: Zhenzhen Li, et al.
Published: (2024-11-01)

Contrast-induced acute kidney injury in patients with myocardial infarction non obstruction and with coronary artery obstruction
by: I. S. Grishin, et al.
Published: (2025-03-01)

Sodium–Glucose Cotransporter-2 Inhibitors After Acute Myocardial Infarction
by: Nicia I. Profili, et al.
Published: (2025-03-01)

PCSK9 Inhibitors: Focus on Evolocumab and Its Impact on Atherosclerosis Progression
by: Maram H. Abduljabbar
Published: (2024-11-01)

Risk assessment of contrast-induced acute kidney injury in patients with acute myocardial infarction after coronary angiography and percutaneous coronary intervention
by: A. A. Ursta, et al.
Published: (2021-09-01)

Acute myocardial infarction in patient with myocardial bridging
by: V. D. Syvolap, et al.
Published: (2014-06-01)

Assessment of Trimetazidine Treatment in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention
by: Xiuying Tang, et al.
Published: (2022-01-01)

PCSK9 Inhibitors in Clinical Practice: Experience of a Specialized Lipid Center
by: A. V. Blokhina, et al.
Published: (2022-01-01)

An Updated Meta-Analysis for Safety Evaluation of Alirocumab and Evolocumab as PCSK9 Inhibitors
by: Hye Duck Choi, et al.
Published: (2023-01-01)

Lipid Lowering Treatment and Eligibility for PCSK9 Inhibition in Post-Myocardial Infarction Patients in Italy: Insights from Two Contemporary Nationwide Registries
by: Furio Colivicchi, et al.
Published: (2020-01-01)

Gain of function variants in PCSK9 gene in high risk patients after myocardial infarction with increased lipoprotein (a) values and treated with statins
by: Sabina Ugovšek, et al.
Published: (2025-07-01)

Levels of proprotein convertase subtilisin/kexin type 9 in patients with acute myocardial infarction
by: A. D. Gimadeeva, et al.
Published: (2020-03-01)

Mutual mediation effects of homocysteine and PCSK9 on coronary lesion severity in patients with acute coronary syndrome: interplay with inflammatory and lipid markers
by: Ping Jin, et al.
Published: (2025-01-01)

Plasma tissue plasminogen activator-inhibitor complex levels in acute myocardial infarction patients: an observational study
by: Yi-fan Feng, et al.
Published: (2024-12-01)

The plasma lipopolysaccharide level is associated with contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction
by: Haiqiang Shen, et al.
Published: (2025-07-01)

Predictive value of IBI for acute kidney injury with contrast after PCI in patients with ST-segment elevation myocardial infarction
by: Wenjun Ge, et al.
Published: (2025-03-01)

Inflammatory Biomarkers Predicting Contrast-Induced Acute Kidney Injury in Elderly Patients with ST-Segment Elevation Myocardial Infarction
by: Suleyman Sezai Yildiz, et al.
Published: (2025-05-01)

Ramipril therapy in acute myocardial infarction
by: V. A. Lusov, et al.
Published: (2008-10-01)

Stress hyperglycemia in acute myocardial infarction
by: Koraćević Goran, et al.
Published: (2014-01-01)

ACUTE MYOCARDIAL INFARCTION IN RHEUMATOID ARTHRITIS
by: I. B. Vinogradova, et al.
Published: (2000-02-01)

PREVENTIVE ANGIOPLASTY IN ACUTE MYOCARDIAL INFARCTION
Published: (2016-03-01)

THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL INFARCTION
by: D. P. Sementsov
Published: (2015-12-01)

Reperfusion in acute myocardial infarction patients
by: I. G. Gordeev, et al.
Published: (2006-06-01)

Therapeutic hypothermia in acute myocardial infarction
by: V. V Ryabov, et al.
Published: (2023-08-01)